Stocks

The table gives an overview of all stocks, alphabetically sorted.
 NagaCoin NGC Apr 15, 2021 0.06 +9.36   
 Naka Bodhi Token NBOT Apr 15, 2021 0.04 -0.07   
 Nano NANO Apr 15, 2021 5.46 -4.30   
 Nash Exchange NEX Apr 15, 2021 1.40 -2.20   
 NavCoin NAV Apr 15, 2021 0.76 +3.41   
 Neblio NEBL Apr 15, 2021 4.38 +2.85   
 Nebulas NAS Apr 15, 2021 1.19 -5.72   
 NEM XEM Apr 15, 2021 0.42 +1.32   
 NEO NEO Apr 15, 2021 69.23 -1.26   
 Nervos Network CKB Apr 15, 2021 0.03 -1.26   
 Nest Protocol NEST Apr 15, 2021 0.05 +2.16   
 Neurotoken NTK Apr 15, 2021 0.02 -13.38   
 Newscrypto Coin NWC Apr 15, 2021 0.73 +2.54   
 NewYork Exchange NYE Apr 15, 2021 20.55 +0.73   
 NEXO NEXO Apr 15, 2021 3.78 +10.14   
 NextDAO NAX Apr 15, 2021 0.00 -9.00   
 Nexus NXS Apr 15, 2021 1.44 -2.61   
 Nexxo NEXXO Apr 15, 2021 0.00 +0.55   
 Nimiq NIM Apr 15, 2021 0.01 +3.97   
 Niobium NBC Apr 15, 2021 0.01 +3.22   
 NIX NIX Apr 15, 2021 0.54 +2.60   
 NKN NKN Apr 15, 2021 0.76 -10.43   
 Node NODE Apr 15, 2021 0.00 +36.93   
 NOIA Network NOIA Apr 15, 2021 0.66 -7.26   
 NOKU Master token NOKU Apr 15, 2021 0.19 -1.00   
 NoLimitCoin NLC2 Apr 15, 2021 0.01 -13.36   
 Nuls NULS Apr 15, 2021 1.27 +2.63   
 Numerai NMR Apr 15, 2021 71.74 -1.27   
 Nxt NXT Apr 15, 2021 0.09 +4.35   
 Obits Coin OBITS Apr 15, 2021 0.01 -0.98   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK